TrialClinical cardiology2015

Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.

Heerajnarain Bulluck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.